The breast implants market offers silicone and saline filled breast implant products that are used for breast augmentation and breast reconstruction procedures. Breast augmentation procedures help enhance the size and appearance of breasts for aesthetic purposes, while reconstruction is generally carried out post mastectomy or in cases with congenital breast abnormalities. There has been a steady rise in cosmetic surgeries worldwide as people are becoming more aware about aesthetic appearance and its impact on self-confidence and quality of life. 

The growing emphasis on physical beauty and social acceptance has made breast augmentation one of the most popular cosmetic surgeries globally. Moreover, with advancements in implant technology and materials, safety and comfort of implants have significantly improved over time.

The global Breast Implants Market is estimated to be valued at US$ 1,299.9 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/breast-implants-market-1309

Market key trends:

One of the key trends in the breast implants market is the increased demand for silicone implants over saline implants. Silicone implants have emerged as a preferred choice owing to their soft, subtle feel and look that closely resembles natural breasts. Also, silicone implants last longer than saline implants and do not require replacement as often. Despite some controversies in the past regarding safety of silicone, modern cohesive silicone gel implants are considered safe and have an excellent safety record according to leading regulators. This has boosted the adoption of silicone breast implants significantly.

Porter’s Analysis

Threat of new entrants: Low barriers to enter into market discourage new players. Significant capital investment and stringent regulations for product approval pose entry barriers.

Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes like fat grafting. However, buyers bargain for product quality and better after-sales services.

Bargaining power of suppliers: Suppliers of raw materials have low bargaining power due to availability of substitutes and diverse supplier base. They depend on key players for larger orders.

Threat of new substitutes: Substitutes like fat grafting pose threat but lack long term suitability. New substitutes are being developed but are still at nascent stage.

Competitive rivalry: Intense rivalry exists among established global players. Players compete on product differentiation, customer service and geographic expansion to gain higher market share.

Key Takeaways

The global breast implants market is expected to witness high growth. The global Breast Implants Market is estimated to be valued at US$ 1,299.9 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.
The North America region currently dominates the market attributed to high aesthetic awareness and advanced healthcare infrastructure in the region. The Asia Pacific region is expected to witness fastest growth during the forecast period. Countries like China, India and South Korea are emerging as lucrative markets owing to growing medical tourism coupled with rising disposable incomes.

Key players:

Key players operating in the breast implants market are Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd., Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc., and Silimed. They are focusing on new product launches and geographical expansion to strengthen their market presence.